Logo
I

ImmunityBio, Inc.

562 employees

ImmunityBio is a late-stage immunotherapy startup that is developing treatments to drive immunogenic pathways in the fight against cancer.

Basic info

Industry

biotechnology research

Sectors

Cancer
Vaccines
Fusion Proteins
Cell Therapy
Health Diagnostics
Health Care
Oncology
T Cell
Clinical Trials
Therapeutics
Immunotherapy
Infectious Diseases
Natural Killer
Vaccine
COVID-19
Manufacturing
Yeast

Date founded

2014

FAQ